Sydsvenska Kemi sells Vyncolit to Sumitomo Bakelite
Sydsvenska Kemi AB (SSK), the parent company of the Perstorp Group, controlled by the Industri Kapital 2000 Fund, announced the sale of Vyncolit NV and Vyncolit North America Inc (Vyncolit), to Sumitomo Bakelite Co. Ltd (Sumitomo Bakelite) for a cash sum of SEK 856 million. The divestment is in line with Perstorp's strategy to focus on its core business, specialty chemicals.
Vyncolit is active within moldable composites and provides its products mainly to the automotive and electrical industries. The business, which has facilities in Ghent (Belgium) and Manchester (Connecticut, USA), has a turnover of approximately SEK 470 million and employs approximately 300 people. The combination of Vyncolit with Sumitomo Bakelite's existing activities in this area will create a truly global player in the broad sector of value-added plastics.
Vyncolit's development since Industri Kapital's acquisition of Perstorp has been considerable. The business has been able to leverage Perstorp's longstanding experience and know-how within specialty chemicals in order to develop new applications and products. The successful broadening of application areas has increased Vyncolit's co-operation with important customer groups such as the automotive industry - a cooperation which was further strengthened through the acquisition of the moldable composite activities of Rogers Corporation in 2002, enabling Vyncolit to gain a foothold in North America.
Most read news
Organizations
Other news from the department business & finance

Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Lilly Announces Acquisition of Hypnion - Deal shall bolster Lilly's Sleep Disorder Research with promising insomnia compound

Chemical scissors enable structural editing of layered materials - Structural editing strategy of MAX phases and MXenes
New cost-effective instrument measures molecular dynamics on a picosecond timescale
Tiniest imperfections make big impacts in nano-patterned materials

Two tricks for biocatalysis - Plasmas usually have a destructive effect on enzymes - But in this instance, they supply them with a building block for biocatalysis at the push of a button
Orion sues Sun Pharmaceuticals in the U.S. to enforce a patent for Stalevo - Company states the realisation of generic competition is neither certain nor imminent
